Header Logo

Connection

Matthew Meriggioli to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Dose-Response Relationship, Drug.
Matthew Meriggioli
Connection Strength
0.037
Dose-Response Relationship, Drug
  1. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018 12; 17(12):1043-1052.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.